Chlorpropamide |
Diabinese |
Article: Chlorpropamide
![]() | |
| Chlorpropamide | |
| Systematic (IUPAC) name | |
| N-(4-chlorophenyl)sulfonylmethanamide | |
| Identifiers | |
| CAS number | 94-20-2 |
| ATC code | A10BB02 |
| PubChem | 2727 |
| DrugBank | APRD00029 |
| Chemical data | |
| Formula | C10H13N2ClO3S |
| Mol. weight | 276.741 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | 36 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. | ? |
| Legal status | |
| Routes | ? |
Chlorpropamide is a sulphonylurea drug used to treat type 2 diabetes mellitus. Its renal clearance and long half-life cause hypoglycemia as a side effect more frequently than newer sulphonylureas.
| Oral antidiabetic drugs (A10B) edit |
|---|
| A10BA - Biguanide - {02-metformin} |
| A10BB - Sulfonylureas - {01-glibenclamide (glyburide)} {02-chlorpropamide} {03-tolbutamide} {05-tolazamide} {07-glipizide} {08-gliquidone} {09-gliclazide} {12-glimepiride} |
| A10BF - Alpha-glucosidase inhibitor - {01-acarbose} |
| A10BG - Thiazolidinediones (TZD) - {01-troglitazone} {02-rosiglitazone} {03-pioglitazone} |
| A10BX - Meglitinide - {02-repaglinide} {03-nateglinide} |
| no ATC - Dipeptidyl peptidase-4 (DPP-4) inhibitors - {sitagliptin} {vildagliptin} |
Categories: Pharmacology stubs | Sulfonylureas

Not Signed In - 


